Navigation Links
Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Date:11/7/2012

platform to potential new drug candidates such as etirinotecan pegol is therefore very uncertain and unpredictable and could unexpectedly fail at any time; (v) patents may not issue from our patent applications for etirinotecan pegol, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (vi) the outcome of any existing or future intellectual property or other litigation related to our proprietary drug candidates.  Other important risks and uncertainties are detailed in our reports and other filings with the Securities and Exchange Commission ("SEC"), including without limitation, those risks and uncertainties set forth in our quarterly report on Form 10-Q for the quarter ended June 30, 2012, filed with the SEC on August 9, 2012. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.Nektar Investor Inquiries:Jennifer Ruddock/Nektar Therapeutics

(415) 482-5585Susan Noonan/SA Noonan Communications, LLC

(212) 966-3650Nektar Media Inquiries: Mary Cunney(917) 208-2162 Mike Huckman (646) 500-7631 (1) American Cancer Society, 2007 Global Cancer Facts and Figures Report.

(2) American Cancer Society, 2009 Global Cancer Facts and Figures Report.

(3) Alvaro and Perez, Mayo Clin Proc. 2009; 84(6):533-545


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
3. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
4. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
7. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
10. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
11. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015  Fair Rate Funding, a leader ... jury in Delaware found Thursday ... to treat pelvic organ prolapse (POP) and Stress Urinary ... company executives hid the design flaws from the plaintiff, ... http://photos.prnewswire.com/prnh/20150529/219354LOGO Transvaginal mesh, also known ...
(Date:5/29/2015)... Eli Lilly and Company (NYSE: LLY ... Healthcare Conference on Tuesday, June 9, 2015. Jeffrey ... Health, will participate in a fireside chat at 2:20 ... audio webcast will be available on the "Webcasts & ... . A replay of the fireside chat will be ...
(Date:5/29/2015)... DIEGO and BOSTON , ... leader in instrument development, custom automation, and contract manufacturing, ... of the Nanopatch™ needle-free drug delivery technology, have been ... development of the Nanopatch Jet Coating Instrument , ... delivery research and product development.  The award was announced ...
Breaking Medicine Technology:TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3Lilly to Participate in Goldman Sachs Global Healthcare Conference 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3
... Ill., Sept. 29 Earlier this year, the National Association ... introduced to the AWARxE campaign, which was created and implemented ... power of the campaign, NABP obtained the AWARxE program so ... The Foundation was inspired to create the ...
... Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution -- ABBOTT PARK, Ill., Sept. 29 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
Cached Medicine Technology:NABP Purchases AWARxE Consumer Protection Program 2Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution 2Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution 3Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution 4Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution 5Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution 6Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution 7
(Date:5/29/2015)... 2015 β€œIn the current environment ... federal regulations, we provide education that will help ... are suffering from pain, within the boundaries of ... professor of rehabilitation medicine and President/Medical Director of ... Kansas. , A new flight of PAINWeekEnd Regional ...
(Date:5/29/2015)... 29, 2015 Ready to hit the road? ... all drivers to get their vehicles ready. With handicapped vehicles, ... Advanced Driving Systems (ADS) is ready to help drivers get ... for summer road trips. , When planning for the big ... ensure that the trip goes smoothly and they are prepared ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 ... leap forward in Los Angeles thanks to the efforts ... Dr. Mohebi has combined ARTAS hair restoration ... most advanced hair restoration procedures available anywhere. , A ... of directly and individually harvesting hair follicle grafts from ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
(Date:5/29/2015)... 2015 Abington Hospital – Jefferson ... first hospitals in the nation to join the ... practices and work toward achieving the Baby-Friendly USA© ... focusing on maternity care practices leading to Baby-Friendly ... and Prevention, EMPower is aimed at increasing breastfeeding ...
Breaking Medicine News(10 mins):Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2
... HILL, N.C., April 18 Sales force ... The ability of senior,management to effectively disseminate ... selling time is integral to the overall ... study, "U.S. Sales Communications Excellence:,Resources, Structure and ...
... Fla., April 18 Breckenridge Pharmaceutical,Inc. announced today ... granted,final approval for the Company,s Abbreviated New Drug ... Nordisk,s Activella Tablets,(Estradiol/Norethindrone Acetate 1.0mg / 0.5mg) Tablets., ... Activella(R), a,brand product marketed by Novo Nordisk(R), which ...
... receptors could lead to treatments for other addictions as ... Using gene therapy to increase the level of dopamine ... reduced their desire for cocaine by 75 percent, U.S. ... team at the U.S. Department of Energy,s Brookhaven National ...
... disparities were result of age, body composition , , FRIDAY, ... related to younger age or body composition may not ... higher levels of creatinine than white patients, says a ... , Creatinine is a standard indicator of kidney function. ...
... 18 The American,Chemistry Council (ACC) respects the ... safety of Canadians with respect to the use ... from their,government., Consistent with the safety evaluations ... draft assessment released today by,Health Canada confirms that ...
... April 18 Sales leaders and,organizations that ... mastered,the art of motivating their sales representatives. ... sales personnel can use the key findings,discovered ... "Rewarding &,Recognizing Top-Performing Sales People.",( http://www3.best-in-class.com/dr295.htm ), ...
Cached Medicine News:Health News:Complementary Excerpt Available from Best Practices: Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications 2Health News:Gene Therapy in Rats Reduces Cocaine Use 2Health News:Muscle Mass May Not Explain High Creatinine in Black Kidney Patients 2Health News:Health Canada Draft Assessment Supports Safety of Bisphenol A 2Health News:Health Canada Draft Assessment Supports Safety of Bisphenol A 3Health News:Complementary Excerpt Available from Best Practices: Rewarding and Recognizing Top-Performing Sales People 2
... available techniques for prenatal diagnosis (CVS and ... use a small but significant chance of ... care offers invasive prenatal baby gender testing ... chromosomal or genetic abnormalities are greater than ...
... pharmDx Kit is a direct fluorescence in ... determine HER2 gene amplification in formalin-fixed, paraffin-embedded ... determined from the ratio between the number ... HER2 gene probe (red signals) and the ...
... Anesthesia and Respiratory Products, ,Westmed designs, ... for Anesthesia and Respiratory professionals. Our mission ... enhance the clinician's ability to deliver quality ... the bottom line. , ,Our web ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
Medicine Products: